TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Private sector picks up slack in vaccination drive

The Russian Direct Investment Fund (RDIF), which funds the development of the Sputnik V vaccine, said it would be able to supply shots for up to 30 percent of Indonesia’s population this year.

Ardila Syakriah (The Jakarta Post)
Premium
Jakarta
Sun, April 11, 2021

Share This Article

Change Size

Private sector picks up slack in vaccination drive Elderly people sit distanced from one another as they wait their turn for a pre-COVID-19 vaccination screening at a community health center (Puseksmas) in Palmerah, West Jakarta, on Feb. 25. The government aims to inoculate some 21 million people aged 60 and above, but global supply shortages threaten to delay vaccine deliveries to Indonesia and elsewhere. (JP/Ardila Syakriah)

A

s the government slows down its free inoculation rollout for priority groups due to limited vaccine supplies, a separate, private vaccination scheme has potentially secured 40 million doses of vaccines for the employees of participating companies. The doses are expected to arrive gradually and as early as late April.

State-owned pharmaceutical company PT Bio Farma president director Honesti Basyir recently told lawmakers that vaccine supplies for the private program currently in discussion involved 15 million doses of dual-shot vaccines and 5 million single-doses from Chinese firms Sinopharm and CanSino Biologics, respectively, and 20 million dual-doses from Russia’s Sputnik V.

Bio Farma has been tasked with procuring and distributing COVID-19 vaccines for both the government’s free vaccination drive and the private scheme — the latter of which has been dubbed the Gotong Royong (mutual cooperation) program.

All three vaccines have yet to receive emergency approval from the Food and Drug Monitoring Agency (BPOM), but agency head Penny K. Lukito said it expected to issue the approval for Sputnik V in late April after receiving a complete set of data on efficacy, safety and quality. 

Sputnik V deliveries, according to Honesti, could start sometime between late April and July, with around 5 million doses per month, as soon as BPOM issues the approval.

Sinopharm might start deliveries in the fourth week of April with 500,000 doses, another 7 million doses by July and 7.5 million doses in the second half of this year, Honesti said. Meanwhile, CanSino is expected to send 3 million doses between July and September and another 2 million in the last quarter of 2021.

Read also: Indonesian government promises big, then falters in vaccine procurement

to Read Full Story

  • Unlimited access to our web and app content
  • e-Post daily digital newspaper
  • No advertisements, no interruptions
  • Privileged access to our events and programs
  • Subscription to our newsletters
or

Purchase access to this article for

We accept

TJP - Visa
TJP - Mastercard
TJP - GoPay

Redirecting you to payment page

Pay per article

Private sector picks up slack in vaccination drive

Rp 29,000 / article

1
Create your free account
By proceeding, you consent to the revised Terms of Use, and Privacy Policy.
Already have an account?

2
  • Palmerat Barat No. 142-143
  • Central Jakarta
  • DKI Jakarta
  • Indonesia
  • 10270
  • +6283816779933
2
Total Rp 29,000
{

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.